Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and pr… Read more
Arjo AB (publ) - Asset Resilience Ratio
Arjo AB (publ) (ARRJF) has an Asset Resilience Ratio of -1.67% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2023)
This chart shows how Arjo AB (publ)'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Arjo AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-270.00 Million | -1.67% |
| Total Liquid Assets | $-270.00 Million | -1.67% |
Asset Resilience Insights
- Limited Liquidity: Arjo AB (publ) maintains only -1.67% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Arjo AB (publ) Industry Peers by Asset Resilience Ratio
Compare Arjo AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Arjo AB (publ) (2013–2023)
The table below shows the annual Asset Resilience Ratio data for Arjo AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.49% | $-76.00 Million | $15.44 Billion | +1.18pp |
| 2022-12-31 | -1.67% | $-270.00 Million | $16.17 Billion | +0.31pp |
| 2021-12-31 | -1.98% | $-289.00 Million | $14.61 Billion | -1.58pp |
| 2020-12-31 | -0.40% | $-55.00 Million | $13.86 Billion | -0.08pp |
| 2019-12-31 | -0.32% | $-46.00 Million | $14.42 Billion | -- |
| 2018-12-31 | 0.00% | $0.00 | $13.14 Billion | -- |
| 2017-12-31 | 0.00% | $0.00 | $12.21 Billion | -- |
| 2016-12-31 | 0.79% | $116.00 Million | $14.71 Billion | +0.40pp |
| 2015-12-31 | 0.39% | $55.00 Million | $14.02 Billion | +0.07pp |
| 2014-12-31 | 0.32% | $48.00 Million | $14.82 Billion | -0.29pp |
| 2013-12-31 | 0.61% | $81.00 Million | $13.22 Billion | -- |